Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. Rabies virus is transferred to humans through the saliva of an animal who is infected by it. Inactivated rabies virus (IRV) is injected before or after the infection of the virus in 1 ml doses having 2.5 IU per ml of rabies virus antigen.
This report contains market size and forecasts of Inactivated Polio and Rabies Vaccines in global, including the following market information:
Global Inactivated Polio and Rabies Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Inactivated Polio and Rabies Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Inactivated Polio and Rabies Vaccines companies in 2021 (%)
The global Inactivated Polio and Rabies Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inactivated Polio Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Inactivated Polio and Rabies Vaccines include Bharat Biotech, BIO-MED, Serum Institute of India, Kedrion Biopharma, GlaxoSmithKline, Merck and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inactivated Polio and Rabies Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inactivated Polio and Rabies Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inactivated Polio and Rabies Vaccines Market Segment Percentages, by Type, 2021 (%)
Inactivated Polio Vaccine
Inactivated Rabies Vaccine
Global Inactivated Polio and Rabies Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inactivated Polio and Rabies Vaccines Market Segment Percentages, by Application, 2021 (%)
Pediatrics
Adults
Global Inactivated Polio and Rabies Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inactivated Polio and Rabies Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inactivated Polio and Rabies Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Inactivated Polio and Rabies Vaccines revenues share in global market, 2021 (%)
Key companies Inactivated Polio and Rabies Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Inactivated Polio and Rabies Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bharat Biotech
BIO-MED
Serum Institute of India
Kedrion Biopharma
GlaxoSmithKline
Merck
Pfizer